Experts Discuss How Expanding Traditional Value Frameworks Can Address Inequities in Health Outcomes
Expanding traditional value frameworks to include inequality and the factors that contribute to inequality is the first step to addressing disparities in health outcomes. In this exclusive AMJC video interview by Matthew Gavidia, PRECISIONheor’s Jason Shafrin and Meena Venkatachalam discuss how utilizing multi-criteria decision analysis and distributional cost effect analysis can assist in deriving data and taking action on these issues.
Four Ways Pharma Can Use Digital To Keep Patients The Central Focus
In 2001 the Institute of Medicine named patient centered care one of six keys to delivering high-quality care. How can pharma companies keep patients center stage while in the midst of a digital transformation? Precision’s Marty Samples discusses the four fundamentals of patient-centered care and how pharma marketers can use digital to execute on them.
Opportunities and Challenges of Value-Based Health Care: How Brazil Can Learn from U.S. Experience
The Brazilian health system, a mix of private and public payers, predominantly relies on a fee for service model. In order to meet the health care needs of a growing population but also control spending, Brazil needs to evolve its payment models toward value-based health care. Precision’s Jeremy Schafer and 2iM Inteligencia Medica’s Cesar Abicalaffe analyze the lessons the Brazilian healthcare system can learn from the United States, where value-based care is slowly but surely becoming the norm.
On-demand Webinar: A Novel Method to Improve Validity and Relevance Of Indirect Comparisons and Network Meta-Analysis
Watch PRECISIONheor’s Jeroen Jansen, and partner David Phillippo, as they provide an introduction to a novel method, called multilevel network meta-regression (ML-NMR). The method addresses several limitations with current methods, including synthesizing networks of any size and availability of IPD or aggregate studies, and – crucially for decision-making – producing estimates in any target population of interest.
How Copay Management by Payers Is Evolving
Pharmaceutical manufacturers and payers have been involved in a back and forth dance regarding patient cost share practices – each action is met with a reaction. Precision’s Jeremy Schafer looks at the complex battle between pharmaceutical manufacturers and payers for balance between medication access and budget management.
From Supplier to Public Health Player: The Changing Role of Biopharma Companies
Access challenges to cell and gene therapy are well documented. Precision’s Christina Poschen and David Carr discuss how some innovative manufacturers are moving away from the role of being purely a researcher and manufacturer and toward involvement at the point of diagnosis through manufacturing and delivery to patient access support in order to address those challenges head on.
2020 Priorities Include Inter-Operability, Cybersecurity and SDoH
Who typically has responsibility for Identity and Access Management within health plan organizations, and how does this role impact or protect their healthcare analytics objectives? Precision’s Dominic Galante contributes to the Thought Leaders Corner in this month’s Care Analytics News.
Precision Medicine Group has a new website!
With the discipline of precision medicine as the foundation, Precision Medicine Group has Precision for Medicine’s next-gen clinical development and Precision Value & Health’s industry leading commercialization working together to accelerate the delivery of life science innovations. Visit the new Precision Medicine Group website, and see how we’re moving science closer to health.
On-demand Webinar: Using HEOR Methods to Reduce Health Inequalities
Current social and political events have brought renewed attention to the levels of systemic inequalities faced by millions of minorities in the United States and around the world. Adding to the discussion, Precision will explore how innovative health economics and outcomes research (HEOR) methods can be leveraged to quantify the full value new treatments that improve health outcomes for underserved communities.
Creating Incentives To Narrow The Gap In Health Outcomes: Expanding Value Assessment To Incorporate Health Inequality
Over the past decade, healthcare has slowly been moving from a focus on volume to value based healthcare. With the COVID-19 pandemic, compelling aspects of alternative payment models (APM) are causing providers, payers, and pharmaceutical manufacturers to take notice. Precision’s Elizabeth Oyekan identifies four emerging trends in APM practices that are enabling APMs to be better prepared to deliver high-quality and more affordable care during the COVID-19 pandemic.